BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9616710)

  • 1. Controlled drug release from self-catalyzed poly(ortho esters).
    Ng SY; Vandamme T; Taylor MS; Heller J
    Ann N Y Acad Sci; 1997 Dec; 831():168-78. PubMed ID: 9616710
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and characterization of self-catalyzed poly(ortho ester).
    Sintzel MB; Heller J; Ng SY; Taylor MS; Tabatabay C; Gurny R
    Biomaterials; 1998; 19(7-9):791-800. PubMed ID: 9663755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant and controlled release of dexamethasone and 5-fluorouracil from poly(ortho ester).
    Einmahl S; Zignani M; Varesio E; Heller J; Veuthey JL; Tabatabay C; Gurny R
    Int J Pharm; 1999 Aug; 185(2):189-98. PubMed ID: 10460914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro drug release from self-catalyzed poly(ortho ester): case study of 5-fluorouracil.
    Sintzel MB; Heller J; Ng SY; Tabatabay C; Schwach-Abdellaoui K; Gurny R
    J Control Release; 1998 Nov; 55(2-3):213-8. PubMed ID: 9795063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres for the sustained release of 5-fluorouracil.
    Khang G; Kim SW; Cho JC; Rhee JM; Yoon SC; Lee HB
    Biomed Mater Eng; 2001; 11(2):89-103. PubMed ID: 11352116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering Biocompatible Hydrogels from Bicomponent Natural Nanofibers for Anticancer Drug Delivery.
    Xu J; Liu S; Chen G; Chen T; Song T; Wu J; Shi C; He M; Tian J
    J Agric Food Chem; 2018 Jan; 66(4):935-942. PubMed ID: 29283261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(D,L-lactide-ran-epsilon-caprolactone)-poly(ethylene glycol)-poly(D,L-lactide-ran-epsilon-caprolactone) as parenteral drug-delivery systems.
    Cho H; Chung D; Jeongho A
    Biomaterials; 2004 Aug; 25(17):3733-42. PubMed ID: 15020149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained local drug delivery from a radiopaque implanted reservoir.
    Koole LH; Kruft MA; Aldenhoff YB; van 't Oost NE; van Kroonenburgh MJ; van der Veen FH
    Nat Biotechnol; 1998 Feb; 16(2):172-6. PubMed ID: 9487525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermosensitive hydrogel based on poly(ether-ester anhydride) nanoparticle as drug delivery system: preparation, characterization and biocompatibility.
    Zhang J; Liang Y; Li N; Li X; Hu R; Xing J; Deng L; Hu F; Dong A
    Colloids Surf B Biointerfaces; 2012 Aug; 96():56-61. PubMed ID: 22516713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of biodegradable polyesters with various microstructures for highly controlled release of epirubicin and cyclophosphamide.
    Żółtowska K; Piotrowska U; Oledzka E; Luchowska U; Sobczak M; Bocho-Janiszewska A
    Eur J Pharm Sci; 2017 Jan; 96():440-448. PubMed ID: 27742595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-responsive biocompatible fluorescent polymer nanoparticles based on phenylboronic acid for intracellular imaging and drug delivery.
    Li S; Hu K; Cao W; Sun Y; Sheng W; Li F; Wu Y; Liang XJ
    Nanoscale; 2014 Nov; 6(22):13701-9. PubMed ID: 25278283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained release of antineoplastic drugs from chitosan-reinforced alginate microparticle drug delivery systems.
    Yu CY; Zhang XC; Zhou FZ; Zhang XZ; Cheng SX; Zhuo RX
    Int J Pharm; 2008 Jun; 357(1-2):15-21. PubMed ID: 18313867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled drug release from poly(ortho esters).
    Heller J
    Ann N Y Acad Sci; 1985; 446():51-66. PubMed ID: 3925854
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug delivery from catalysed erodible polymeric matrices of poly(ortho ester)s.
    Shih C; Higuchi T; Himmelstein KJ
    Biomaterials; 1984 Jul; 5(4):237-40. PubMed ID: 6487705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface-Eroding Poly(ortho ester amides) for Highly Efficient Oral Chemotherapy.
    Wei B; Tao Y; Wang X; Tang R; Wang J; Wang R; Qiu L
    ACS Appl Mater Interfaces; 2015 May; 7(19):10436-45. PubMed ID: 25921065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres.
    Blanco-Príeto MJ; Campanero MA; Besseghir K; Heimgatner F; Gander B
    J Control Release; 2004 May; 96(3):437-48. PubMed ID: 15120900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled drug release from bioerodible hydrophobic ointments.
    Heller J; Ng SY; Fritzinger BK; Roskos KV
    Biomaterials; 1990 May; 11(4):235-7. PubMed ID: 2383618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and in vitro release behaviour of 5-fluorouracil-loaded microspheres based on poly (L-lactide) and its carbonate copolymers.
    Zhu KJ; Zhang JX; Wang C; Yasuda H; Ichimaru A; Yamamoto K
    J Microencapsul; 2003; 20(6):731-43. PubMed ID: 14594662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of poly(ortho esters): a historical overview.
    Heller J
    Biomaterials; 1990 Nov; 11(9):659-65. PubMed ID: 2090300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodegradable Poly(ester-urethane) Carriers Exhibiting Controlled Release of Epirubicin.
    Żółtowska K; Piotrowska U; Oledzka E; Kuras M; Zgadzaj A; Sobczak M
    Pharm Res; 2017 Apr; 34(4):780-792. PubMed ID: 28120174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.